News about Global Pharma

Zydus Receives Final Approval from USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg (RLD: Accutane® Capsules, 10 mg, 20 mg and 40 mg: RS: Claravis 10 mg, 20 mg, 30 mg and 40 mg).

Global Pharma | 01/09/2023 | By Manvi |  733

Filament Health and Reset Pharma Enter Licensing Agreement for Botanical Psilocybin Drug Candidate

Reset Pharma will use its botanical psilocybin drug candidate, PEX010, for a phase 2 clinical trial studying demoralization syndrome.

Global Pharma | 01/09/2023 | By Manvi |  993

Lupin Launches Propranolol Long-Acting Capsules in Canada

Propranolol LA's launch caters to the needs of Canadian patients,reaffirming Lupin's commitment.

Global Pharma | 31/08/2023 | By Manvi |  867

Strides Gets USFDA Approval for Mycophenolate Mofetil for Oral Suspension

The company has 280 cumulative ANDA filings with USFDA.

Global Pharma | 31/08/2023 | By Manvi |  906

Unichem Laboratories Gets ANDA Approval for Prasugrel Tablets

Prasugrel tablets are indicated to reduce the rate of thrombotic CV events in patients.

Global Pharma | 31/08/2023 | By Manvi |  579

Ajanta Pharma Receives Final Approval for Topiramate Extended Release Capsules from USFDA

The company has received 50 final ANDA approvals, out of which 41 are commercialized.

Global Pharma | 31/08/2023 | By Manvi |  1086

Hvivo to Open Larger Facility in London to Meet Rising Demand

The new facility will be located in Canary Wharf.

Global Pharma | 30/08/2023 | By Manvi |  563

Orchid Pharma to Enter Consumer Business

The company manufactures formulations and APIs across segments.

Global Pharma | 30/08/2023 | By Manvi |  1196

Sun Pharma Appoints Jaydeep Shah as CMO of Consumer Health Business

He has also had a long stint with Unilever, fulfilling various leadership roles at Indian and global levels. He started his career with CEAT as a Marketing management trainee.
<br />

Global Pharma | 29/08/2023 | By Manvi |  818

Sandoz Acquires Astellas' Antifungal Agent Mycamine

The company stated "Through this acquisition of the leading global echinocandin, one of three major antifungal classes, Sandoz significantly reinforces its global hospital offering and leading anti-infectives portfolio.

Global Pharma | 29/08/2023 | By Manvi |  656